Drug Trial Radar · NCT01199289
A Study to Evaluate the Dosing of AMG 827 for Subjects With Inadequately Controlled Asthma
Last checked: Nov 20, 2026Latest source record: Nov 26, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
315
Actual
Start
Oct 4, 2010
Primary completion
Dec 21, 2011
Study completion Dec 21, 2011
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Sep 10, 2010
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine if AMG 827 is effective compared to placebo as measured by change in Asthma Control Questionnaire (ACQ) composite scores.
Conditions
- Asthma
Interventions
AMG 827Drug
SC injection.
PlaceboDrug
SC injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Asthma Control Questionnaire (ACQ) Composite Scores to Week 12Time frame: Baseline and Week 12
Locations
49 sites in 10 countries. Site status is shown where the registry gives one.
Research Site
Encinitas, California
Research Site
Huntington Beach, California
Research Site
Los Angeles, California
Research Site
San Diego, California
Research Site
Stockton, California
Research Site
Colorado Springs, Colorado
Research Site
Stockbridge, Georgia
Research Site
Baltimore, Maryland
Research Site
North Dartmouth, Massachusetts
Research Site
St Louis, Missouri
Research Site
Bozeman, Montana
Research Site
Bellevue, Nebraska
Research Site
Skillman, New Jersey
Research Site
Rockville Centre, New York
Research Site
High Point, North Carolina
Research Site
Cincinnati, Ohio
Research Site
Lake Oswego, Oregon
Research Site
Medford, Oregon
Research Site
Pittsburgh, Pennsylvania
Research Site
Dallas, Texas
Research Site
El Paso, Texas
Research Site
Madison, Wisconsin
Research Site
Feldbach, Austria
Research Site
Hallein, Austria
Research Site
Vienna, Austria
Research Site
Brussels, Belgium
Research Site
Leuven, Belgium
Research Site
Liège, Belgium
Research Site
Calgary, Alberta, Canada
Research Site
Ottawa, Ontario, Canada
Research Site
Toronto, Ontario, Canada
Research Site
Helsinki, Finland
Research Site
Jyväskylä, Finland
Research Site
Turku, Finland
Research Site
Edelény, Hungary
Research Site
Mátraháza, Hungary
Research Site
Tatabánya, Hungary
Research Site
Törökbálint, Hungary
Research Site
Zalaegerszeg - Pozva, Hungary
Research Site
Rotterdam, Netherlands
Showing 40 of 49 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.